- Filed
- Oct 9, 2024 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · Sep 18, 2024 | 956.53M sh |
| Shares Diluted restated | Q1 2024 · Mar 31, 2024 | 767.6M sh |
| Shares Diluted restated | Q1 2024 · Mar 31, 2023 | 618.97M sh |
| Capex restated | Q1 2024 · Mar 31, 2024 | $189.39K |
| Capex | Q1 2024 · Mar 31, 2023 | $0 |
| Operating Cash Flow restated | Q1 2024 · Mar 31, 2024 | −$104.25K |
| Operating Cash Flow restated | Q1 2024 · Mar 31, 2023 | −$336.79K |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $114.16K |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $125.4K |
| Stockholders Equity restated | Q1 2024 · Mar 31, 2024 | $15.09M |
| Stockholders Equity restated | Q1 2024 · Dec 31, 2023 | −$2.07M |
| Stockholders Equity restated | Q1 2024 · Mar 31, 2023 | −$2.42M |
| Stockholders Equity restated | Q1 2024 · Dec 31, 2022 | −$2.53M |
| Current Liabilities restated | Q1 2024 · Mar 31, 2024 | $3.38M |
| Current Liabilities restated | Q1 2024 · Dec 31, 2023 | $2.79M |
| Total Liabilities restated | Q1 2024 · Mar 31, 2024 | $3.53M |
| Total Liabilities restated | Q1 2024 · Dec 31, 2023 | $2.94M |
| Current Assets restated | Q1 2024 · Mar 31, 2024 | $485.46K |
| Current Assets restated | Q1 2024 · Dec 31, 2023 | $652.66K |
| Total Assets restated | Q1 2024 · Mar 31, 2024 | $18.62M |
| Total Assets restated | Q1 2024 · Dec 31, 2023 | $865.75K |
| Eps Diluted | Q1 2024 · Mar 31, 2024 | $0.00 |
| Eps Diluted | Q1 2024 · Mar 31, 2023 | $0.00 |
| Eps Basic | Q1 2024 · Mar 31, 2024 | $0.00 |
| Eps Basic | Q1 2024 · Mar 31, 2023 | $0.00 |
| Sga Expense restated | Q1 2024 · Mar 31, 2024 | $2.91M |
| Sga Expense | Q1 2024 · Mar 31, 2023 | $770.99K |
| Rd Expense | Q1 2024 · Mar 31, 2024 | $25.54K |
| Rd Expense | Q1 2024 · Mar 31, 2023 | $80.78K |
| Net Income restated | Q1 2024 · Mar 31, 2024 | −$3.15M |
| Net Income restated | Q1 2024 · Mar 31, 2023 | −$229.84K |
| Operating Income restated | Q1 2024 · Mar 31, 2024 | −$3.08M |
| Operating Income restated | Q1 2024 · Mar 31, 2023 | −$184.11K |
| Gross Profit restated | Q1 2024 · Mar 31, 2024 | $384.16K |
| Gross Profit | Q1 2024 · Mar 31, 2023 | $763.89K |
| Cost Of Revenue restated | Q1 2024 · Mar 31, 2024 | $165.39K |
| Cost Of Revenue | Q1 2024 · Mar 31, 2023 | $311.69K |
| Revenue restated | Q1 2024 · Mar 31, 2024 | $549.55K |
| Revenue restated | Q1 2024 · Mar 31, 2023 | $1.08M |